Doxycycline in the Coronavirus Disease 2019 Therapy
Karolina Dorobisz,1 Tadeusz Dorobisz,2 Dariusz Janczak,2 Tomasz Zatoński1 1Department of Otolaryngology, Head and Neck Surgery, Wroclaw Medical University, Wroclaw, Poland; 2Department of Vascular Surgery, Wroclaw Medical University, Wroclaw, PolandCorrespondence: Karolina Dorobisz Email...
Guardado en:
Autores principales: | Dorobisz K, Dorobisz T, Janczak D, Zatoński T |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/67750291f4de4589a94402750e56b5e8 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
An Up-to-Date Overview of Therapeutic Agents for the Treatment of COVID-19 Disease
por: Mulaw Belete T
Publicado: (2020) -
N-Acetylcysteine to Combat COVID-19: An Evidence Review
por: Shi Z, et al.
Publicado: (2020) -
Cardiovascular Considerations in COVID19: A Comprehensive Review
por: Keihanian F, et al.
Publicado: (2020) -
Immunological and Preventive Effects of Hochuekkito and Kakkonto Against Coronavirus Disease in Healthcare Workers: A Retrospective Observational Study
por: Keiko Ogawa-Ochiai, et al.
Publicado: (2021) -
Clinical Effect of Doxycycline Combined with Compound Sulfamethoxazole and Rifampicin in the Treatment of Brucellosis Spondylitis
por: Yang XM, et al.
Publicado: (2021)